An Indian drugmaker has partnered with Russia's Sputnik V coronavirus vaccine developer on Friday to produce 200 million doses of the Russian coronavirus vaccine.

Indian drugmaker enters into partnership to produce 200 million doses of Sputnik V vaccine

stelis-biopharma

Stelis Biopharma, News on Stelis Biopharma, stories on Stelis Biopharma, articles on Stelis Biopharma, Stelis Biopharma stories at Wion, Stelis Biopharma news, Stelis Biopharma latest news

stelis biopharma

Indian drugmaker enters into partnership to produce 200 million doses of Sputnik V vaccine